NYSE:IQV - IQVIA Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $173.35
  • Forecasted Upside: 2.05 %
  • Number of Analysts: 17
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 15 Buy Ratings
  • 0 Strong Buy Ratings
$169.87
▼ -2.13 (-1.24%)
1 month | 3 months | 12 months
Get New IQVIA Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IQV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IQV

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$173.35
▲ +2.05% Upside Potential
This price target is based on 17 analysts offering 12 month price targets for IQVIA in the last 3 months. The average price target is $173.35, with a high forecast of $224.00 and a low forecast of $110.00. The average price target represents a 2.05% upside from the last price of $169.87.
Buy
The current consensus among 17 contributing investment analysts is to buy stock in IQVIA. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 2 strong buy ratings
  • 15 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/5/2019
  • 1 strong buy ratings
  • 16 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/3/2019
  • 1 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/2/2019
  • 0 strong buy ratings
  • 15 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/1/2020
  • 0 strong buy ratings
  • 16 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/30/2020
  • 0 strong buy ratings
  • 16 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/28/2020
  • 0 strong buy ratings
  • 16 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/27/2020
  • 0 strong buy ratings
  • 15 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/26/2020

Latest Recommendations

  • 0 strong buy ratings
  • 15 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/22/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$180.00 ➝ $196.00Low
i
10/21/2020UBS GroupBoost Price TargetBuy$204.00 ➝ $224.00Medium
i
10/21/2020Morgan StanleyBoost Price TargetOverweight$182.00 ➝ $195.00Medium
i
10/21/2020Piper SandlerBoost Price TargetNeutral$140.00 ➝ $179.00Medium
i
10/21/2020MizuhoBoost Price TargetBuy$180.00 ➝ $190.00Medium
i
7/23/2020Robert W. BairdBoost Price TargetOutperform$156.00 ➝ $180.00High
i
7/23/2020Morgan StanleyBoost Price TargetOverweight$158.00 ➝ $182.00High
i
7/23/2020Wells Fargo & CompanyBoost Price TargetOverweight$155.00 ➝ $185.00High
i
7/23/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$145.00 ➝ $180.00High
i
7/23/2020MizuhoBoost Price TargetBuy$153.00 ➝ $180.00High
i
7/23/2020CitigroupBoost Price TargetBuy$160.00 ➝ $200.00High
i
7/7/2020Bank of AmericaBoost Price TargetBuy$145.00 ➝ $156.00Medium
i
7/6/2020StephensInitiated CoverageEqual Weight$150.00Low
i
4/29/2020SunTrust BanksBoost Price TargetBuy$128.00 ➝ $172.00Medium
i
4/29/2020Piper SandlerBoost Price Target$115.00 ➝ $138.00High
i
4/29/2020Stifel NicolausBoost Price TargetBuy$159.00 ➝ $165.00High
i
4/29/2020Wells Fargo & CompanyBoost Price TargetOverweight$140.00 ➝ $150.00High
i
4/29/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$150.00 ➝ $145.00High
i
4/29/2020CitigroupBoost Price TargetTop Pick ➝ Buy$155.00 ➝ $160.00High
i
4/28/2020UBS GroupLower Price TargetBuy$200.00 ➝ $162.00High
i
4/9/2020CitigroupLower Price TargetBuy$195.00 ➝ $155.00Low
i
4/8/2020Piper SandlerLower Price Target$163.00 ➝ $115.00High
i
4/6/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$190.00 ➝ $150.00High
i
4/3/2020MizuhoLower Price TargetBuy$153.00 ➝ $120.00Medium
i
4/2/2020Credit Suisse GroupLower Price TargetOutperform$175.00 ➝ $157.00Low
i
Rating by Erin Wright at Credit Suisse Group AG
3/31/2020Stifel NicolausLower Price TargetBuy$194.00 ➝ $159.00Low
i
3/30/2020Wells Fargo & CompanyLower Price TargetOverweight$190.00 ➝ $140.00Low
i
3/27/2020Morgan StanleyLower Price TargetOverweight$170.00 ➝ $158.00High
i
3/26/2020BarclaysLower Price TargetOverweight$192.00 ➝ $166.00Low
i
3/24/2020CfraLower Price TargetBuy$185.00 ➝ $110.00Medium
i
3/23/2020Jefferies Financial GroupLower Price TargetBuy$195.00 ➝ $127.00High
i
3/17/2020SunTrust BanksLower Price TargetBuy$184.00 ➝ $128.00Low
i
3/2/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$190.00High
i
2/13/2020Piper SandlerBoost Price Target$145.00 ➝ $163.00Medium
i
2/13/2020UBS GroupBoost Price TargetBuy$187.00 ➝ $200.00Low
i
2/13/2020Robert W. BairdBoost Price TargetOutperform$172.00 ➝ $181.00Low
i
2/13/2020JPMorgan Chase & Co.Boost Price TargetOverweight$180.00 ➝ $195.00Low
i
2/13/2020CitigroupBoost Price TargetBuy$185.00 ➝ $195.00Low
i
2/12/2020Stifel NicolausBoost Price TargetBuy$180.00 ➝ $194.00Low
i
2/12/2020CfraUpgradeHold ➝ Buy$148.00 ➝ $185.00Low
i
1/7/2020Wells Fargo & CompanyInitiated CoverageOverweight$180.00Low
i
1/6/2020CitigroupInitiated CoverageBuy$185.00Medium
i
12/20/2019Credit Suisse GroupReiterated RatingBuy$170.00N/A
i
Rating by Erin Wright at Credit Suisse Group AG
12/13/2019CfraUpgradeSell ➝ HoldLow
i
11/14/2019Wolfe ResearchUpgradePeer Perform ➝ OutperformLow
i
7/25/2019Credit Suisse GroupBoost Price TargetOutperform$165.00 ➝ $170.00Low
i
7/25/2019Wells Fargo & CompanyBoost Price TargetOutperform$170.00 ➝ $178.00Low
i
7/25/2019JPMorgan Chase & Co.Boost Price TargetOverweight$160.00 ➝ $180.00Low
i
7/15/2019BarclaysSet Price TargetBuy$180.00Medium
i
Rating by Jack Meehan at Barclays PLC
6/27/2019SunTrust BanksBoost Price TargetBuy$155.00 ➝ $175.00Low
i
6/21/2019MizuhoUpgradeNeutral ➝ Buy$150.00 ➝ $175.00High
i
Rating by Ann Hynes at Mizuho
6/19/2019MizuhoBoost Price TargetNeutral ➝ Neutral$145.00 ➝ $150.00High
i
6/19/2019Credit Suisse GroupBoost Price TargetOutperform$159.00 ➝ $165.00High
i
6/19/2019Morgan StanleyBoost Price TargetOverweight$156.00 ➝ $170.00High
i
6/19/2019Stifel NicolausBoost Price TargetBuy$167.00 ➝ $178.00High
i
6/19/2019William BlairReiterated RatingOutperformHigh
i
5/28/2019SVB LeerinkInitiated CoverageOutperform ➝ Outperform$160.00Low
i
Rating by D. Larsen at SVB Leerink LLC
4/2/2019Wolfe ResearchInitiated CoverageMarket PerformLow
i
3/18/2019BarclaysBoost Price TargetOverweight ➝ Overweight$160.00 ➝ $167.00Low
i
2/25/2019ArgusBoost Price TargetBuy ➝ Buy$140.00 ➝ $160.00Low
i
2/19/2019Wells Fargo & CompanyBoost Price TargetOutperform ➝ Outperform$140.00 ➝ $160.00Low
i
2/15/2019BarclaysReiterated RatingBuy$155.00Low
i
2/15/2019UBS GroupSet Price TargetBuy$155.00 ➝ $170.00Low
i
2/15/2019Piper Jaffray CompaniesBoost Price TargetNeutral$148.00Low
i
1/18/2019Jefferies Financial GroupUpgradeHold ➝ Buy$136.00 ➝ $150.00High
i
1/11/2019The Goldman Sachs GroupUpgradeBuy ➝ Conviction-BuyLow
i
12/3/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$130.00 ➝ $145.00High
i
Rating by Ricky Goldwasser at Morgan Stanley
10/23/2018Royal Bank of CanadaBoost Price TargetOutperform$137.00Low
i
Rating by George Hill at Royal Bank of Canada
10/23/2018Piper Jaffray CompaniesBoost Price TargetNeutral$131.00High
i
10/23/2018BarclaysBoost Price TargetOverweight ➝ Overweight$130.00 ➝ $140.00High
i
10/9/2018UBS GroupInitiated CoverageBuy ➝ BuyLow
i
10/2/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$143.00 ➝ $146.00Low
i
8/31/2018Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$136.00 ➝ $145.00Low
i
8/23/2018ArgusSet Price TargetBuy$136.00Low
i
Rating by Jasper Hellweg at Argus
8/13/2018Wells Fargo & CompanyBoost Price TargetOutperform ➝ Outperform$120.00 ➝ $140.00Low
i
8/6/2018MizuhoSet Price TargetHold$120.00Low
i
Rating by Ann Hynes at Mizuho
7/25/2018Piper Jaffray CompaniesReiterated RatingHold$97.00High
i
7/25/2018SunTrust BanksBoost Price TargetBuy$140.00High
i
7/25/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$127.00 ➝ $143.00High
i
7/25/2018JPMorgan Chase & Co.Boost Price TargetOverweight$135.00High
i
7/25/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$121.00 ➝ $130.00High
i
7/25/2018BarclaysReiterated RatingOverweight ➝ Overweight$120.00 ➝ $130.00High
i
7/25/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$128.00 ➝ $150.00High
i
7/25/2018Royal Bank of CanadaReiterated RatingBuy$129.00High
i
Rating by George Hill at Royal Bank of Canada
7/25/2018Bank of AmericaUpgradeNeutral ➝ Buy$135.00High
i
7/20/2018Jefferies Financial GroupReiterated RatingHold$119.00Low
i
7/19/2018Royal Bank of CanadaReiterated Rating$110.25$128.00Low
i
Rating by George Hill at Royal Bank of Canada
7/3/2018Raymond JamesUpgradeOutperform ➝ Strong-BuyMedium
i
6/18/2018Robert W. BairdUpgradeNeutral ➝ OutperformHigh
i
4/13/2018The Goldman Sachs GroupUpgradeNeutral ➝ BuyMedium
i
4/9/2018ArgusBoost Price TargetBuy ➝ Buy$110.00 ➝ $112.00Low
i
3/7/2018SunTrust BanksUpgradeHold ➝ BuyLow
i
2/15/2018Royal Bank of CanadaSet Price TargetBuy$118.00Low
i
Rating by George Hill at Royal Bank of Canada
2/15/2018Piper Jaffray CompaniesReiterated RatingHold$103.00Low
i
2/15/2018JPMorgan Chase & Co.Boost Price TargetOverweight$115.00 ➝ $120.00Low
i
1/24/2018MizuhoSet Price TargetHold$97.00Low
i
Rating by Ann Hynes at Mizuho
1/22/2018SunTrust BanksReiterated RatingHold$110.00Low
i
1/18/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$112.00High
i
12/15/2017Mitsubishi UFJ Financial GroupInitiated CoverageNeutral$112.00Low
i
Rating by J. Twizell at Mitsubishi UFJ Financial Group
11/10/2017KeyCorpReiterated RatingOverweight ➝ Sector Weight$100.00N/A
i
11/9/2017Morgan StanleyBoost Price TargetOverweight$96.00 ➝ $121.00N/A
i
11/9/2017MizuhoDowngradeBuy ➝ Neutral$90.00N/A
i
11/3/2017SunTrust BanksReiterated RatingHold$114.00N/A
i
10/31/2017Credit Suisse GroupReiterated RatingOutperform$115.00 ➝ $125.00N/A
i
10/30/2017Jefferies Financial GroupBoost Price TargetHold$107.00 ➝ $110.00N/A
i
10/27/2017BarclaysBoost Price TargetOverweight$100.00 ➝ $120.00N/A
i
Rating by Douglas Tsao at Barclays PLC
10/27/2017Stifel NicolausUpgradeHold ➝ Buy$92.00 ➝ $128.00N/A
i
10/16/2017Credit Suisse GroupReiterated RatingOutperform$98.00 ➝ $110.00N/A
i
10/9/2017Robert W. BairdReiterated RatingHold$98.00N/A
i
9/24/2017KeyCorpReiterated RatingBuy$100.00Low
i
9/19/2017Royal Bank of CanadaInitiated CoverageOutperform ➝ Outperform$116.00Low
i
9/18/2017ArgusBoost Price TargetBuy$98.00 ➝ $104.00Low
i
8/7/2017CitigroupBoost Price TargetNeutral$96.00 ➝ $97.00Low
i
8/4/2017Stifel NicolausReiterated RatingHold$87.00 ➝ $92.00Low
i
8/4/2017Jefferies Financial GroupReiterated RatingHold$94.00Low
i
8/4/2017BarclaysSet Price TargetBuy$98.00 ➝ $100.00Low
i
8/4/2017William BlairUpgradeMarket Perform ➝ Outperform$70.10 ➝ $93.42Low
i
Rating by J. Kreger at William Blair
7/17/2017BarclaysReiterated RatingOverweight$90.00 ➝ $98.00Low
i
7/7/2017Robert W. BairdUpgradeUnderperform ➝ Neutral$76.00 ➝ $93.00Medium
i
6/28/2017CitigroupReiterated RatingNeutral$87.00 ➝ $96.00Low
i
6/6/2017Credit Suisse GroupReiterated RatingOutperform$94.00 ➝ $96.00Low
i
5/15/2017Jefferies Financial GroupBoost Price TargetHold$78.00 ➝ $81.00Low
i
5/5/2017Jefferies Financial GroupReiterated RatingHold$78.00 ➝ $81.00Low
i
5/4/2017Evercore ISIReiterated RatingIn-Line$84.00 ➝ $88.50Low
i
5/4/2017MizuhoBoost Price TargetBuy ➝ Buy$90.00 ➝ $93.00Low
i
4/3/2017Jefferies Financial GroupReiterated RatingHold$78.00Low
i
3/31/2017Credit Suisse GroupInitiated CoverageOutperform ➝ Outperform$89.00Low
i
2/17/2017Wells Fargo & CompanyUpgradeMarket Perform ➝ OutperformN/A
i
2/15/2017Robert W. BairdDowngradeNeutral ➝ Underperform$80.00 ➝ $74.00N/A
i
2/3/2017Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$81.00 ➝ $80.00N/A
i
12/16/2016The Goldman Sachs GroupDowngradeBuy ➝ Neutral$83.00N/A
i
12/13/2016MizuhoInitiated CoverageNeutral$90.00N/A
i
12/4/2016Pacific CrestSet Price TargetBuy$82.00N/A
i
Rating by Brent Bracelin at Pacific Crest
12/2/2016Bank of AmericaDowngradeBuy ➝ Neutral$89.00N/A
i
12/1/2016Raymond JamesReiterated RatingStrong-Buy ➝ Market PerformN/A
i
12/1/2016William BlairDowngradeOutperform ➝ Market PerformN/A
i
Rating by J. Kreger at William Blair
12/1/2016CitigroupDowngradeStrong-Buy ➝ Market PerformN/A
i
11/30/2016BarclaysReiterated RatingOverweight$90.00N/A
i
10/27/2016Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$75.00 ➝ $72.00N/A
i
10/19/2016Jefferies Financial GroupDowngradeBuy ➝ Hold$79.00N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
10/14/2016Stifel NicolausInitiated CoverageHold$84.00N/A
i
10/5/2016UBS GroupReiterated RatingBuy$78.00 ➝ $90.00N/A
i
Rating by Jon Groberg at UBS Group AG
10/5/2016The Goldman Sachs GroupUpgradeNot Rated ➝ Buy$94.00N/A
i
8/18/2016ArgusReiterated RatingBuy$75.00 ➝ $85.00N/A
i
7/28/2016UBS GroupReiterated RatingBuy$78.00N/A
i
Rating by Jon Groberg at UBS Group AG
7/28/2016Pacific CrestBoost Price TargetOverweight$75.00 ➝ $82.00N/A
i
7/28/2016Deutsche Bank AktiengesellschaftBoost Price TargetBuy$71.00 ➝ $81.00N/A
i
Rating by George Hill at Deutsche Bank Aktiengesellschaft
7/28/2016CitigroupBoost Price TargetNeutral$72.00 ➝ $75.00N/A
i
7/28/2016KeyCorpReiterated RatingBuyN/A
i
Rating by Donald Hooker at KeyCorp
7/27/2016Evercore ISIBoost Price TargetHold$70.00 ➝ $78.00N/A
i
Rating by Ross Muken at Evercore ISI
7/11/2016Avondale PartnersUpgradeMarket Perform ➝ Outperform$62.00 ➝ $87.00N/A
i
Rating by G. Bolan at Avondale Partners
6/28/2016UBS GroupReiterated RatingBuy$78.00N/A
i
6/8/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by David Windley at Jefferies Financial Group Inc.
6/6/2016ArgusReiterated RatingBuyN/A
i
5/22/2016KeyCorpReiterated RatingBuyN/A
i
5/12/2016Wells Fargo & CompanyDowngradeOutperform ➝ Market PerformN/A
i
5/4/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by David Windley at Jefferies Financial Group Inc.
5/4/2016CitigroupDowngradeBuy ➝ Neutral$76.00 ➝ $72.00N/A
i
5/4/2016Evercore ISIDowngradeBuy ➝ Hold$74.00N/A
i
5/4/2016Robert W. BairdDowngradeOutperform ➝ Neutral$76.00 ➝ $74.00N/A
i
5/3/2016Avondale PartnersDowngradeMarket Outperform ➝ Market Perform$58.00 ➝ $62.00N/A
i
Rating by G. Bolan at Avondale Partners
3/28/2016SunTrust BanksDowngradeBuy ➝ Neutral$73.00N/A
i
2/16/2016KeyCorpLower Price Target$89.00 ➝ $82.00N/A
i
2/15/2016Avondale PartnersUpgradeUnderperform ➝ Market PerformN/A
i
2/12/2016Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$78.00 ➝ $71.00N/A
i
2/11/2016Avondale PartnersUpgradeUnderperform ➝ Market PerformN/A
i
12/17/2015The Goldman Sachs GroupUpgradeBuy ➝ Conviction-Buy$86.00N/A
i
(Data available from 11/26/2015 forward)
IQVIA logo
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and contract research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support services; and strategic planning and design services, as well as clinical trial, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. The company has a strategic alliance with ACCORD-2 to provide single research platform to speed development of new COVID-19 treatments. IQVIA Holdings Inc. serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Read More

Today's Range

Now: $169.87
$169.34
$171.99

50 Day Range

MA: $166.71
$153.99
$173.93

52 Week Range

Now: $169.87
$81.79
$180.77

Volume

817,074 shs

Average Volume

1,339,839 shs

Market Capitalization

$32.57 billion

P/E Ratio

186.67

Dividend Yield

N/A

Beta

1.45